Kenis Y
Dermatologica. 1978;157(6):407-14.
The clinical experience with chemotherapy in mycosis fungoides is practically limited to the action of different types of chemotherapeutic agents on the lesions in far-advanced cases. A large number of agents from almost all classes--alkylating agents, antimetabolites, antibiotics, alkaloids, hormones--have some efficacy in clearing skin lesions. Despite this fact, combination chemotherapy has been the subject of a very small number of publications with conflicting results. The influence on survival, the comparative effects of combination versus single-agent chemotherapy, the value of chemotherapy combined to other treatment modalities have not been submitted to scientific evaluation. Considering the low frequency of the disease and the great variability of the clinical picture, it seems mandatory to implement large cooperative trials, possibly on an international scale.
蕈样肉芽肿化疗的临床经验实际上仅限于在晚期病例中不同类型化疗药物对皮损的作用。几乎所有种类的大量药物——烷化剂、抗代谢物、抗生素、生物碱、激素——在清除皮肤损害方面都有一定疗效。尽管如此,联合化疗仅有少量相互矛盾结果的出版物。其对生存率的影响、联合化疗与单药化疗的比较效果、化疗联合其他治疗方式的价值均未得到科学评估。鉴于该疾病的低发病率和临床表现的巨大变异性,开展大规模合作试验(可能在国际范围内)似乎是必要的。